Avalon GloboCare Corp.
(NASDAQ:ALBT)
$1.87
0.03 (1.63%)
At Close: 4:00 PM
$1.79
0.02 (1.13%)
Pre Market: 4:19 AM
ALBT Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
ALBT Stock Price Today
Avalon GloboCare Corp. (ALBT) stock rallied over 1.63% intraday to trade at $1.87 a share on NASDAQ. The stock opened with a loss of -1.09% at $1.82 and touched an intraday high of $1.93, rising 1.63% against the last close of $1.84. The Avalon GloboCare Corp. in stock market went to a low of $1.83 during the session.
ALBT Stock Snapshot
$1.84
Prev. Close
18.7 Million
Market Cap
$1.83
Day Low
$1.82
Open
9.86 Million
Number of Shares
$1.93
Day High
N/A
P/E ratio
-1.26
EPS (TTM)
0.09
Cash Flow per Share
4.87
Free Float in %
-0.01
Book Value
9847.00
Volume
ALBT Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2023-02-14 | $3.83 | $3.98 | $3.66 | $3.76 | 70060.00 |
| 2023-02-13 | $3.60 | $3.85 | $3.46 | $3.84 | 193300.00 |
| 2023-02-10 | $3.09 | $3.42 | $3.08 | $3.28 | 58600.00 |
| 2023-02-08 | $3.17 | $3.24 | $3.11 | $3.11 | 7762.00 |
| 2023-02-07 | $3.20 | $3.25 | $3.13 | $3.19 | 14300.00 |
| 2023-02-06 | $3.14 | $3.27 | $3.09 | $3.23 | 18200.00 |
| 2023-02-03 | $3.03 | $3.34 | $3.03 | $3.30 | 34290.00 |
| 2023-02-02 | $3.00 | $3.21 | $3.00 | $3.16 | 13700.00 |
| 2023-02-01 | $3.01 | $3.12 | $2.83 | $3.04 | 30600.00 |
| 2023-01-31 | $3.24 | $3.24 | $2.97 | $3.02 | 73000.00 |
Contact Details
4400 Route 9 SouthFreehold, NJ 07728US
Website:https://www.avalon-globocare.com
Contact #:732 780 4400
Company Information
Employees5.00
Beta0.56
Sales or Revenue$1.16 Million
5Y Sales Change2.20%
Fiscal Year EndsDec. 2022
SectorReal Estate
IndustryReal Estate Services
About Company
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry. The company is headquartered in Freehold, New Jersey.
Frequently Asked Questions
What is the current Avalon GloboCare Corp. (ALBT) stock price?
Avalon GloboCare Corp. (NASDAQ: ALBT) stock price is $1.87 in the last trading session. During the trading session, ALBT stock reached the peak price of $1.93 while $1.83 was the lowest point it dropped to. The percentage change in ALBT stock occurred in the recent session was 1.63% while the dollar amount for the price change in ALBT stock was $0.03.
ALBT's industry and sector of operation?
The NASDAQ listed ALBT is part of Real Estate Services industry that operates in the broader Real Estate sector. Avalon GloboCare Corp. , together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China.
Who are the executives of ALBT?
Ms. Meng Li
Chief Operating Officer & Sec.
Dr. David K. Jin M.D., Ph.D.
Chief Executive Officer, Pres & Director
Ms. Meng Li
Chief Operating Officer, Sec. & Director
Ms. Meng Li
COO & Sec.
How ALBT did perform over past 52-week?
ALBT's closing price is 0.12% higher than its 52-week low of $1.65 where as its distance from 52-week high of $8.05 is -0.76%.
How many employees does ALBT have?
Number of ALBT employees currently stands at 5.00. ALBT operates from 4400 Route 9 South</br>Freehold, NJ 07728</br>US.
Link for ALBT official website?
Official Website of ALBT is: https://www.avalon-globocare.com
How do I contact ALBT?
ALBT could be contacted at phone #732 780 4400 and can also be accessed through its website. ALBT operates from 4400 Route 9 South</br>Freehold, NJ 07728</br>US.
How many shares of ALBT are traded daily?
ALBT stock volume for the day was 9847.00 shares. The average number of ALBT shares traded daily for last 3 months was 208.9 Thousands.
What is the market cap of ALBT currently?
The market value of ALBT currently stands at $18.7 Million with its latest stock price at $1.87 and 9.86 Million of its shares outstanding.